Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

7.310 +0.020 (+0.27%)
Streaming Delayed Price Updated: 9:34 AM EDT, Apr 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bionano Genomics Inc

< Previous 1 2 3 4 5 Next >
Bionano Genomics Users Present the Saphyr System As a Novel Diagnostic Tool for Hematological Malignancies at ASH 2020
From GlobeNewswire News Releases
Bionano Genomics and its Users Present the Saphyr System for Optical Genome Mapping and Various Advancements in Clinical Variant Detection at AMP 2020
From GlobeNewswire News Releases
Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update
Company to host conference call today, November 12, at 4:30 pm ET 
From GlobeNewswire News Releases
Multi-Center Evaluation of Bionano Optical Genome Mapping by Cytogenetics Thought Leaders in the US Leads to Recommendation for Bionano’s Saphyr to Replace Karyotyping as First-Line Test for Detection
From GlobeNewswire News Releases
Largest Study To-Date Focused on Undiagnosed Genetic Disease Patients Reveals That Bionano’s Optical Genome Mapping Technology Can Diagnose Significantly More Patients Than Standard of Care Methods Al
Publication from UCSF shows Bionano’s optical genome mapping technology can detect pathogenic variants missed by whole exome sequencing and by chromosomal microarray in patients with rare genetic... 
From GlobeNewswire News Releases
Prowess of Bionano Genomics’ Saphyr System in Uncovering Novel Genetic Variations That Cause Cancer and Genetic Disease in Full Display at ASHG 2020
Top researchers present discoveries in cancer predisposition, neurodegenerative diseases, microdeletion syndromes and other genetic disorders made using Bionano’s optical genome mapping technology 
From GlobeNewswire News Releases
Rockefeller University Scientist Uses Bionano Saphyr to Analyze Genomes of Patients and Animals Susceptible to COVID-19
Using Bionano data in comparative genomics analysis of patients with severe disease and animals that are susceptible to SARS-CoV-2 against patients and animals resistant to disease may reveal... 
From GlobeNewswire News Releases
Bionano Genomics Releases Major Update to Its Suite of Software Tools That Simplifies Clinical Analysis, Reduces Time to Actionable Results and Makes Adoption by Clinical Labs Easier
Reduced compute time, faster variant analysis, more comprehensive clinical annotation and streamlined workflow for non-human model genomes used in drug development improve Saphyr’s best in class... 
From GlobeNewswire News Releases
Bionano Genomics' Saphyr System Shown to be Indispensable for the Analysis of Certain Genetic Disease Causing Variants
Recent publication shows Saphyr’s unique capability in resolving extremely complex structural variants that can cause common genetic disorders called microdeletion syndromes 
From GlobeNewswire News Releases
Bionano Genomics to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 12
From GlobeNewswire News Releases
Bionano's Saphyr Plays Essential Role in Identifying Three Previously Unknown Genetic Mutation Types in Cancer in Study from Weill Cornell
Publication in the peer-reviewed journal Cell identifies three new distinct classes of structural variations associated with poor outcomes in breast and ovarian cancer, gastrointestinal cancers, and... 
From GlobeNewswire News Releases
Boston Children’s Hospital Is Using Bionano’s Saphyr To Study Children With Severe COVID-19 Disease
The genomes of at least 20 patients with Multisystem Inflammatory Syndrome in Children and unaffected controls to be analyzed on Saphyr at Boston Children’s Hospital 
From GlobeNewswire News Releases
Bionano Genomics Announces Positive Outcome of Its Special Stockholder Meeting
Stockholders voted in favor of proxy proposal to increase the authorized share count 
From GlobeNewswire News Releases
Bionano Genomics Announces Continued Expansion of Global Business with Adoption of Saphyr for Next-Generation Cytogenomics in Eastern Europe and Australia
Leading hospitals in Slovenia and Australia adopt Saphyr to improve the diagnosis and treatment of leukemias 
From GlobeNewswire News Releases
German Accreditation of Laboratory Developed Tests on Bionano’s Saphyr System Accelerates Utilization in Clinical Diagnostics
First official European accreditation of Saphyr-based laboratory developed test helps pave the way for broader adoption of Saphyr for clinical diagnostics applications 
From GlobeNewswire News Releases
Bionano to Present at the September 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
From GlobeNewswire News Releases
Bionano Data Provides Understanding of Repeat Expansion Disorders Causing Muscular Dystrophy and ALS
From GlobeNewswire News Releases
Bionano Genomics Continues to See Expansion in the Adoption of Saphyr for Digital Cytogenetics at Leading Medical Institutions
From GlobeNewswire News Releases
Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy
From GlobeNewswire News Releases
Bionano Genomics Announces Continued Expansion of European Business With Adoption of Saphyr at Three of Europe’s Largest Pediatric Hospitals in Spain, Italy and France
Leading children’s hospitals adopt Saphyr to improve the diagnosis and treatment of childhood leukemias 
From GlobeNewswire News Releases
Vertebrate Genome Project Rules Bionano Optical Mapping Technology As Essential Part of Assembling Reference Quality Genomes
Publication evaluating all modern technologies for sequencing and genome assembly selects Bionano optical maps to build all vertebrate reference genomes 
From GlobeNewswire News Releases
Bionano Genomics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Independent Proxy Advisory Firm ISS Recommends Bionano Stockholders Vote “FOR” Authorized Shares Increase Proposal
Bionano Urges Stockholders to Vote “For” Authorized Shares Increase Proposal 
From GlobeNewswire News Releases
Bionano Genomics Data is a Key to Understanding Cancer Genome Structures That Make Tumors Grow Aggressively
Nature Communications paper describes circular genome structures that make cancers like glioblastoma multiforme, the cancer that killed senators Ted Kennedy and John McCain, so deadly 
From GlobeNewswire News Releases
Bionano Genomics Announces Adjournment of Special Meeting of Stockholders to September 29, 2020
Special Meeting of Stockholders Adjourned to Allow Additional Time to Secure Sufficient Votes “For” Authorized Shares Increase Proposal 
From GlobeNewswire News Releases
Bionano Genomics Emphasizes the Importance of Supporting the Proxy Proposal to Increase its Authorized Shares
Ahead of the Special Meeting of Stockholders to be held on August 31, 2020, Bionano CEO Erik Holmlin emphasized the potential harm to Bionano without an increase in authorized shares 
From GlobeNewswire News Releases
Bionano Genomics Appoints Tech Executive Christopher Stewart as its Chief Financial Officer to Help Manage, Grow and Expand Bionano’s Global Business
From GlobeNewswire News Releases
Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics
From GlobeNewswire News Releases
Bionano Saphyr Services Offered in CLIA Certified Lab Expands Bionano Genomics’ Clinical Applications
From GlobeNewswire News Releases
Bionano Genomics Appoints Industry Leading Cytogeneticist Dr. Alka Chaubey as the Company’s First Chief Medical Officer to Help Lead the Conversion of Cytogenetics to Digital Cytogenetics with Saphyr
Dr. Chaubey is a key opinion leader in cytogenetics who has developed, validated and commercialized dozens of molecular and cytogenetic tests based on next generation sequencing, microarray and... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.